PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 10, 2025Renal Failure1 citationsOpen Access

Incidence and risk factors for chronic kidney disease after hematopoietic stem cell transplantation

View Full Paper
ATAlina TănaseAAAndreea AndronesiBSBogdan Sorohan

Key Points

  • CKD incidence was 11.7% among patients post-HSCT, with median onset at 6 months.
  • Aging was identified as a significant risk factor, with each additional year increasing CKD risk by 8%.
  • Cox regression analysis detected various predictors, including daily eGFR and disease length impacting renal outcomes.
  • Acute lymphoblastic leukemia correlated with a 63% lower risk for CKD, emphasizing its protective effect in HSCT patients.

Abstract

Chronic kidney disease (CKD) in hematopoietic stem cell transplantation (HSCT) is becoming more common. Only few studies were published during the past 10 years. Identification of risk factors is of outmost importance. We assessed prospectively a cohort of 197 patients who underwent allogeneic HSCT, aiming to evaluate the incidence and risk factors associated with CKD. We registered the persistence of the low GFR. Cox proportional hazard analysis has been used to identify the risk factors. The mean age was 38.7 years (52.8% female). Acute kidney injury was present in 80% patients within 3 months and CKD incidence was 11.7% with a median onset of 6 months. By univariate Cox regression analysis, age (per 1 year) was the only variable associated with CKD (HR= 1.06, 95%, CI= 1.02-1.10, p = 0.001) and baseline creatinine (per 1 mg/dl) presented a trend of association (HR= 4.62, 95%, CI= 0.75-28.42, p = 0.09). Multivariate Cox regression analysis showed that age (per 1 year; HR= 1.08, 95%, CI = 1.02-1.14, p = 0.003) and hematologic disease length (per 1 month; HR = 1.01, 95%, CI= 1.001-1.02, p = 0.02) were positive predictors for CKD, whereas acute lymphoblastic leukemia (HR= 0.37, 95%, CI= 0.20-0.61, p = 0.02) was a negative predictor factor, being associated with a 63% reduction risk for developing CKD. As the prognostic of hematopoietic stem cell transplantation survivors is improving, CKD emerges as an important comorbidity, with hematologic disease length and baseline eGFR being independent risk factors for renal dysfunction.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Tănase et al. (2025) studied this question.

synapsesocial.com/papers/68c1ad5c54b1d3bfb60e54b9https://doi.org/10.1080/0886022x.2025.2535517
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia/lymphoma2018 · 26 citations
  2. 2Chronic Kidney Disease after Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation2007 · 57 citations
  3. 3Radiation-induced kidney toxicity: molecular and cellular pathogenesis2021 · 162 citations
  4. 4Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation–Associated Thrombotic Microangiopathy2022 · 99 citations
  5. 5The impact of progressive chronic kidney disease on health-related quality-of-life: a 12-year community cohort study2019 · 50 citations